1. Scrip
  2. >>Business

France is next in Merck KGaA's drip drip approach to job cuts

 
• By Eleanor Malone

Merck KGaA is planning to cut 267 pharma jobs in France as part of its efficiency drive announced earlier this year. The company has announced its intention to reduce its 1,270-strong workforce at Lyon-based Merck Serono France and says it intends to favour voluntary departures to limit dismissals. It will offer an early retirement plan as well as a scheme to support professional projects, it declared.

Merck KGaA is planning to cut 267 pharma jobs in France as part of its efficiency drive announced earlier this year. The company has announced its intention to reduce its 1,270-strong workforce at Lyon-based Merck Serono France and says it intends to favour voluntary departures to limit dismissals. It will offer an early retirement plan as well as a scheme to support professional projects, it declared.

The reorganisation affects sales force, marketing, pharma distribution and global functions based in Lyon, as well as support functions. Merck...

More from Business

More from Scrip

China Signals Restarting IPOs For Unprofitable Biotechs

 
• By Dexter Jie Yan

The China Securities Regulatory Commission has proposed a new “growth tier” for the STAR Market of the Shanghai Stock Exchange, to reinstate the market’s listing standards for unprofitable firms.

BIO Notebook: Woodcock Calls For Doing The Right Thing, Dealmaking Remains Constrained

 
• By Mandy Jackson, Joseph Haas, and Sarah Karlin-Smith

Highlights from Day Four of the BIO International Convention include Woodcock offering practical advice on rare disease trials, the sorry state of dealmaking mid-year, Novartis discussing its approach to partnering, and Generate looking for funding to move into Phase III.

Syncona Looks To Go Private As Market Decline Deepens

 
• By Andrew McConaghie

While some are calling for Syncona to be wound up, the UK-based company believes many existing and new investors will back the creation of new private fund.